Zentalis Pharmaceuticals, Inc. financial data

Symbol
ZNTL on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 745% % -0.51%
Debt-to-equity 29% % 12%
Return On Equity -51% % -17%
Return On Assets -40% % -14%
Operating Margin -615% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72,250,779 shares 1.4%
Common Stock, Shares, Outstanding 72,245,529 shares 1.5%
Entity Public Float $231,600,000 USD -85%
Common Stock, Value, Issued $72,000 USD 1.4%
Weighted Average Number of Shares Outstanding, Basic 72,139,000 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 72,139,000 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $26,865,000 USD -34%
Research and Development Expense $110,780,000 USD -41%
General and Administrative Expense $69,817,000 USD 10%
Operating Income (Loss) $165,264,000 USD 21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $149,521,000 USD 34%
Income Tax Expense (Benefit) $205,000 USD -183%
Net Income (Loss) Attributable to Parent $149,316,000 USD 17%
Earnings Per Share, Basic -2 USD/shares 14%
Earnings Per Share, Diluted -2 USD/shares 14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $39,072,000 USD -5.4%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD
Assets, Current $288,302,000 USD -28%
Deferred Income Tax Assets, Net $107,000 USD
Property, Plant and Equipment, Net $2,927,000 USD -42%
Operating Lease, Right-of-Use Asset $30,188,000 USD -9.6%
Goodwill $0 USD -100%
Assets $327,250,000 USD -27%
Accounts Payable, Current $7,031,000 USD -14%
Employee-related Liabilities, Current $8,029,000 USD -26%
Accrued Liabilities, Current $30,137,000 USD -35%
Liabilities, Current $37,168,000 USD -32%
Operating Lease, Liability, Noncurrent $36,708,000 USD -9.3%
Other Liabilities, Noncurrent $500,000 USD -50%
Liabilities $74,376,000 USD -23%
Accumulated Other Comprehensive Income (Loss), Net of Tax $186,000 USD -88%
Retained Earnings (Accumulated Deficit) $1,156,239,000 USD -15%
Stockholders' Equity Attributable to Parent $252,874,000 USD -29%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $252,874,000 USD -29%
Liabilities and Equity $327,250,000 USD -27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $32,636,000 USD 37%
Net Cash Provided by (Used in) Financing Activities $189,000 USD 2600%
Net Cash Provided by (Used in) Investing Activities $40,475,000 USD -34%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 72,245,529 shares 1.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,028,000 USD -16%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41,699,000 USD -5.1%
Deferred Tax Assets, Valuation Allowance $247,025,000 USD 13%
Deferred Tax Assets, Gross $255,988,000 USD 11%
Operating Lease, Liability $40,457,000 USD -6.5%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $150,724,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid $55,291,000 USD -11%
Property, Plant and Equipment, Gross $5,588,000 USD -38%
Operating Lease, Liability, Current $3,749,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,451,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,278,000 USD 7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14,834,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,760,000 USD 4.1%
Deferred Tax Assets, Operating Loss Carryforwards $98,506,000 USD 1.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $14,810,000 USD 251%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,930,000 USD 2.2%
Additional Paid in Capital $1,408,855,000 USD 3.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $899,000 USD -31%
Deferred Tax Assets, Net of Valuation Allowance $8,963,000 USD -14%
Share-based Payment Arrangement, Expense $48,963,000 USD -1.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%